Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.

about

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.

Item

http://www.wikidata.org/entity/Q52619047

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Treatment Options for Paediatr ...... : Current Standard and beyond.

@en

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma

@nl

type

Item

label

Treatment Options for Paediatr ...... : Current Standard and beyond.

@en

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma

@nl

prefLabel

Treatment Options for Paediatr ...... : Current Standard and beyond.

@en

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma

@nl

P1476

Treatment Options for Paediatr ...... ): Current Standard and beyond

@en

P2093

G A Amos Burke

http://www.w3.org/2001/XMLSchema#string

P2860

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma

PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?

Novel immunotherapies in lymphoid malignancies

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

P31

scholarly article

P356

10.3390/CANCERS10040099

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29601554

http://www.w3.org/2001/XMLSchema#string

P932

5923354

http://www.w3.org/2001/XMLSchema#string